AmpliPhi Biosciences Corporation Announces $18 Million Private Placement

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

RICHMOND, VA. & COLWORTH, England & SYDNEY--(BUSINESS WIRE)--AmpliPhi BioSciences Corporation (OTCBB: APHB), the global leader in the development of bacteriophage-based antibacterial therapies to treat drug resistant infections, announced today that it has entered into a definitive stock purchase agreement to raise approximately $18 million in a private placement financing. Pursuant to the stock purchase agreement, the Company will issue an aggregate of 72,003,000 shares of the Company’s common stock at a price per share of $0.25. Estimated net proceeds from the placement will be $16.9 million.

Help employers find you! Check out all the jobs and post your resume.

Back to news